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The mycobacterial cell wall component lipoarabinomannan (LAM) has been described as one of the
key virulence factors of Mycobacterium tuberculosis. Modiﬁcation of the terminal arabinan residues of
this lipoglycan with mannose caps in M. tuberculosis or with phosphoinositol caps in Mycobacterium
smegmatis results in distinct host immune responses. Given that M. tuberculosis typically persists in
the phagosomal vacuole after being phagocytosed by macrophages, we performed a proteomic analysis
of that organelle after treatment of macrophages with LAMs puriﬁed from the two mycobacterial species.
The quantitative changes in phagosomal proteins suggested a distinct role for mannose-capped LAM
in modulating protein trafﬁcking pathways that contribute to the arrest of phagosome maturation.
Enlightened by our proteomic data, we performed further experiments to show that only the LAM
from M. tuberculosis inhibits accumulation of autophagic vacuoles in the macrophage, suggesting a
new function for this virulence-associated lipid.
Keywords: Phagosome • autophagosome • membrane proteome • mycobacterial lipoglycans • mannose-
capped LAM
Introduction
Mycobacterium tuberculosis is an extraordinarily successful
human pathogen with the ability to replicate within the
normally hostile environment of host macrophages. After being
phagocytosed by the macrophage, M. tuberculosis resides in a
membrane-bound vacuole, the phagosome, which normally
undergoes maturation into the phagolysosome that is essential
for eliminating invading microbes and for antigen presenta-
tion.
1 However, M. tuberculosis is able to arrest phagosomal
maturation by interfering with Ca2+ signaling and trafﬁcking
of the Rab family of small GTPases, two important processes
for organelle membrane fusion.
2,3 When residing within a
phagosome, the live bacilli secrets speciﬁc proteins such as
tyrosine phosphatases to reduce the phagosomal level of
phosphatidylinositol 3-phosphate or inhibit host proteins
regulating vacuolar sorting, which all lead to impaired phagoly-
sosomal fusion.
4-6 Arrest of phagosomal maturation (or block
of phago-lysosome fusion) is critical for M. tuberculosis per-
sistence in host macrophages.
1
Apart from secreted proteins, the exotic cell wall components
of pathogenic mycobacteria are thought to be key modulators
of host immune processes, but in most cases, their molecular
effects on host cells are not well understood.
7 The best
characterized are unique mycobacterial lipoglycans termed
lipoarabinomannans (LAM), which are noncovalently associ-
ated with the bacterial plasma membrane and extend to the
exterior of the cell wall.
8,9 LAMs are large, extensively glyco-
sylated, phosphatidylinositol derivatives with heterogeneous
modiﬁcations. Notably, pathogenic M. tuberculosis produces
mannose-capped lipoarabinomannan (ManLAM) structures,
10
whereas the fast-growing nonpathogenic species Mycobacte-
rium smegmatis synthesizes LAM molecules capped with
phosphatidyl-myo-inositol (termed PILAM)
11 (Figure 1).
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profoundly affect their biological activities. For instance, mac-
rophages show signiﬁcantly reduced phagosome-lysosome
fusion after engulﬁng ManLAM-coated microbeads.
12 ManLAM
interacts with the mannose receptor and blocks the rise in
cytosolic Ca2+ that would otherwise accompany mycobacterial
entry into macrophages.
13,14 Free ManLAM can insert into host
cell membranes, leading to membrane reorganization and
disruption of signaling pathways.
15 By contrast, PILAM has
none of these effects. Instead, it is an agonist of Toll-like
receptor 2, which results in secretion of various cytokines and
activation of apoptotic pathways,
16-18 though the notion of its
proinﬂammatory activity has been challenged recently.
19
Motivated by reports suggesting different effects of ManLAM
and PILAM on macrophages, we sought to probe how the two
mycobacterial lipoarabinans affect the molecular properties of
host phagosomes. Previously, we developed a method to purify
the membrane fraction from latex bead-containing (LBC)
phagosomes in order to proﬁle its proteome using mass
spectrometry.
20 Here we modiﬁed our method by combining
Tube-Gel digestion
21 and iTRAQ labeling
22 to study quantitative
changes in the macrophage phagosomal proteome upon
exposure of cells to ManLAM or PILAM. Escherichia coli-derived
lipopolysaccharide (LPS) was used as a third stimulus in order
to identify LAM-speciﬁc effects. From a total list of 823 proteins
found in the phagosomal membranes, we identiﬁed 47 proteins
that were signiﬁcantly up- or down-regulated (>1.25-fold, p <
0.05) by exposure of macrophages to ManLAM but not the
other two lipoglycans. The list of down-regulated proteins
included the autophagy marker LC3. Motivated by this obser-
vation, we investigated the effects of mycobacterial LAMs on
LC3 recruitment to the phagosome as well as autophagy
activation in cultured macrophages. ManLAM inhibited chemi-
cal-induced accumulation of autophagosomes, suggesting a
previously unrecognized function of this virulence factor in
undermining host defense responses.
Experimental Procedures
Reagents. The rat anti-LAMP1 mAb and mouse anti-syntaxin
6 mAb were obtained from BD Biosciences. The goat anti-EEA1
pAb and goat anti-cathepsin D pAb were obtained from Santa
Cruz Biotechnology. The rabbit anti-LC3B pAb and mouse anti-
tubulin mAb were obtained from Sigma. The mouse anti-
transferrin receptor mAb was obtained from Zymed Labora-
tories. All secondary Abs for Western blots were obtained from
SouthernBiotech. FITC-conjugated lectin Concanavalin-A was
obtained from EY Laboratories. Acrylamide/bisacrylamide solu-
tion (40%, 29:1), ammonium persulfate (APS), and tetrameth-
ylenediamine (TEMED) were obtained from Bio-Rad.
Preparation of Lipoglycan-Coated Latex Beads. Latex beads
(1.0 µm microspheres, Polysciences) were washed twice in 0.05
M carbonate-bicarbonate buffer (pH 9.6) by centrifugation at
15 000g for 5 min in 1.5-mL presiliconized low-retention
microtubes (Fisher). The beads in each tube were then resus-
pended in 900 µL of carbonate-bicarbonate buffer before a
certain amount of a speciﬁc lipoglycan was added. Usually, 180
µg of ManLAM or PILAM, or 1.8 µg of LPS was used to coat a
total of 4.55 × 109 latex beads. The beads and lipoglycans were
incubated for1ha t3 7°C on an Eppendorf Thermomixer
(shaking at 1400 rpm). Control beads were prepared by
incubation with buffer alone. The beads were centrifuged and
the supernatant was depleted. The beads were washed once
and then incubated in 1 mL of PBS buffer containing 5% BSA
(Sigma, endotoxin tested) for 0.5 h at 37 °C to block nonspeciﬁc
binding sites. The latex beads were washed with 0.5% BSA in
PBS, resuspended in 1 mL of RPMI-1640 cell culture media,
and stored at 4 °C until use (stable for 1 week). The presence
of mannose residues on latex beads after ManLAM coating was
conﬁrmed by immunoﬂuorescence microscopy using FITC-
conjugated Con A. The other lipids were coated onto beads
using the same protocol, which was presumed to be effective
for all lipoglycans.
Cell Treatment with Lipoglycan-Coated Beads, Phago-
some Isolation, and Membrane Fractionation. The murine
macrophage cell line RAW 264.7 was cultured as a monolayer
in RPMI-1640 (GIBCO, formulated with HEPES and glutamine)
supplemented with 10% fetal bovine serum and 100 units/mL
penicillin/streptomycin. Cells were ﬁrst chilled with 4 °C PBS
for 5 min in order to synchronize phagocytosis. Four popula-
tions of cells were incubated (2 h, 37 °C) with latex beads coated
with a speciﬁc bacterial lipoglycan or control beads without
lipid coating at a multiplicity of infection (MOI) of 50:1 to
generate phagosomes. Cells were then washed with ice-cold
PBS three times. Each cell had internalized 5-10 microbeads
on average as determined by microscopy. After gentle cell lysis
using a Dounce homogenizer to reach 90-95% breakage, the
bead-containing phagosomes were isolated by ultracentrifu-
gation on a sucrose gradient as described by Desjardins and
co-workers.
23
The latex bead-containing (LBC) phagosome fraction was
collected from the top of the sucrose gradient (10-20%
interface) and resuspended in PBS containing protease inhibi-
tor cocktail (Calbiochem). The LBC-phagosome fraction was
washed by ultracentrifugation at 40 000g for 20 min. Each LBC-
phagosome pellet from a given treatment was resuspended in
1.5 mL of 0.2 M Na2CO3 (pH 11.0) containing proteases
inhibitors. The LBC-phagosomes were disrupted by passaging
the suspension 5-7 times through the needle of a 1-mL syringe
(25G). The resulting sample was kept on ice for 30 min before
the membrane fraction was pelleted by centrifugation for 45
min at 200 600g at 4 °C. The pellet was washed with a low-salt
buffer (10 mM triethylammonium bicarbonate (TEAB), Sigma).
A third centrifugation was performed at 100 000g for 15 min
Figure 1. Mycobacterial lipoglycans ManLAM and PILAM. The
structures differ only in their terminal motifs capping the arabinan
moiety. Abbreviations: Ins, inositol; Man, mannose; Ara, arabinose.
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samples were stored at -80 °C prior to protein extraction.
Protein Extraction from Phagsomal Membranes. A solution
of 4% SDS in 400 mM TEAB buffer (50 µL) was added to the
membrane pellet. The resuspended solution was agitated for
30 min at 10 °C on a Thermomixer to extract proteins from
the membrane fraction. After centrifugation at 14 000g for 10
min, the supernatant was collected and diluted with additional
ddH2O so that the ﬁnal protein extract was in 1% SDS and 100
mM TEAB buffer (4-fold dilution). For measuring protein
concentration, we diluted the extracts by another 5-fold with
50 mM Tris-HCl buffer before carrying out the BCA assay
(Pierce).
Trypsin Digestion of Phagosomal Membrane Extracts and
iTRAQ Labeling. For in-solution digestion, 4 µg of protein
derived from the phagosome membrane extract was diluted
either 5-fold or 20-fold in 100 mM TEAB, resulting in a ﬁnal
SDS concentration of 0.2% or 0.01%, respectively. Each protein
sample was treated with TCEP (5 mM, 37 °C for 30 min) and
iodoacetamide (15 mM, for 30 min in the dark) to reduce and
alkylate cysteine residues, then digested with trypsin overnight
(E/S ) 1:20 w/w). In addition to this single enzyme digestion,
we tested the efﬁciency of dual enzyme digestion with both
Lys-C and trypsin. A 5-fold diluted sample was ﬁrst digested
with Lys-C (Promega) for4ha t3 7°C (E/S ) 1:80 w/w) before
the trypsinization under the same condition as above. All
digests were acidiﬁed with 2% formic acid and desalted with a
C18 Ziptip (Millipore).
To test the efﬁciency of in-tube digestion, 5 µg of protein
derived from the phagosome membrane extract was diluted
to 14 µL with 1% SDS in 100 mM TEAB buffer. Cysteine residues
were reduced and alkylated as described earlier. The protein
sample was then mixed with 5 µL of acrylamide/bisacrylamide
(40%, 29:1), 0.7 µL of 1% APS, and 0.3 µL of TEMED. Gel
solidiﬁcation was complete after 30-40 min. The gel impreg-
nated with membrane proteins was cut into small pieces and
washed three times with 50% acetonitrile (ACN) in 100 mM
TEAB buffer. The gel pieces were then dehydrated with pure
ACN and dried using a SpeedVac. A total of 0.5 µg of trypsin
(in 25 mM TEAB buffer, E/S ) 1:10 w/w) was absorbed by the
dried gel, which was then incubated overnight at 37 °C.
Peptides were extracted from the gel with 50 µL of 25 mM TEAB
buffer, 100 µL of 0.1% TFA, and 150 µL of ACN in 0.1% TFA,
sequentially. The solutions were combined and concentrated
using a SpeedVac.
For Tube-Gel digestion of phagosome membrane proteins
before iTRAQ labeling, 20 µg of protein from each extract from
cells treated with different lipid-coated beads was incorporated
into gels using the same protocol, except that 10 mM methyl
methanethiosulfonate (MMTS) replaced iodoacetamide and the
reagent amounts were increased 4-fold. BSA (1 µg) was added
to each sample before gel solidiﬁcation. The residual protein
solution on top of the gel was removed and subjected to a
second solidiﬁcation process. Two gels from the same protein
sample were combined before further treatment described
above. Each peptide extract was concentrated to roughly 20
µL, and 1 M TEAB buffer was added to adjust the ﬁnal buffer
concentration to 400 mM. Four-plex iTRAQ (Applied Biosys-
tems) reagents were reacted with individual protein digests
according to the manufacturer’s protocol. The phagosome
membrane protein preparation and digestion procedures were
performed twice to acquire two biological replicates.
Protein Identiﬁcation by 2D LC-MS/MS and Data Analy-
sis. For comparison of the in-solution and Tube-Gel digestion
efﬁciencies, 0.5 µg of each protein digest was analyzed by
LC-MS using ESI Linear Ion Trap Mass Analyzer (LTQ,
Thermo, Inc.) in a data-dependent acquisition mode. LC
separation was performed on a house-made microcapillary
column (0.100 × 100 mm, 3 µm Magic C18 packing material,
Michrom Bioresources) at a ﬂow rate of 300 nL/min using
buffers 0.1% formic acid (FA) in water (A) and 0.1% FA in ACN
(B). The gradient was 2-10% B for 5 min, 10-40% B for 60
min, 40-90% B for 10 min, and 90% B for 10 min. The major
parameters for LTQ data acquisition were: scan range, 400-2000
m/z; precursor ion selection, six most abundant peaks per scan
for MS/MS; minimal ion signal, 500; and normalized collision
energy, 35.0%.
The iTRAQ-labeled peptide mixtures from Tube-Gel diges-
tion of two experimental replicates were separated by two-
dimensional liquid chromatography and analyzed by ESI-Q-
TOF mass spectrometry. Brieﬂy, the peptide mixture was
separated by off-line strong cation exchange (SCX) chroma-
tography using an Ultimate HPLC with a UV detector (Dionex-
LC Packings, Sunnyvale, CA). Labeled samples were resus-
pended in SCX running buffer (5 mM KH2PO4, 25% ACN, 0.1%
FA) and loaded onto a PolyLC Polysulfethyl A column (2.1 mm
× 200 mm, The Nest Group, Southborough, MA). Peptides were
eluted with increasing concentrations of 800 mM KCl, 5 mM
KH2PO4, 25% ACN, and 0.1% FA using a three step gradient:
0-10% for 10 min, 10-25% for 30 min, and 25-100% for 10
min. Fifteen fractions were collected at a ﬂow rate of 300 µL/
min according peaks observed by UV absorption at 214 nm.
Fractions were partially evaporated to remove ACN on a
SpeedVac and desalted using C18 MacroSpin columns (The
Nest Group, Southborough, MA). Desalted fractions were dried
and reconstituted in 0.1% FA. Each fraction was injected onto
a PepMap100 trapping column (0.3 mm ×5 mm). Reversed-
phase separation was performed on a LC Packings PepMap C18
column (3 µm, 0.075 × 150 mm) at a ﬂow rate of 300 nL/min
using buffers 2% ACN, 0.1% FA (A) and 80% ACN, 0.1% FA (B).
The gradient was 0-35% B for 100 min, 30-100% B for 10 min,
and 100% B for 10 min. The samples from one experiment were
injected into a QSTAR Pulsar-I Hybrid Quadrupole TOF (Ap-
plied Biosystems, Framingham, MA), while the samples from
another replicate were analyzed by a QSTAR Elite Hybrid
Quadrupole TOF (Applied Biosystems, Framingham, MA). The
major parameters for Q-TOF data acquisition were: MS scan
range, 350-1800 m/z; MS/MS scan range, 70-2000 m/z;
precursor ion selection, three most abundant peaks per scan
for MS/MS; minimal ion counts, 30; and automated collision
energy was applied (fragment intensity multiplier ) 2.0).
LC-MS/MS data acquired using a LTQ ion trap mass
spectrometer (Thermo) were searched against the mouse Swiss-
Prot protein database using the SEQUEST algorithm provided
with Bioworks 3.2. SEQUEST results were ﬁltered by Xcorr (+1
> 1.8; +2 > 2.5; +3 > 3.5), DeltaCN > 0.8 and the requirement
of at least two different peptides from a protein. Parent and
product ion mass errors were set at 1.2 and 0.8 Da, respectively.
A static modiﬁcation of carboxyaminomethylation and a vari-
able modiﬁcation of Met oxidation were speciﬁed.
LC-MS/MS data acquired on a Q-TOF for iTRAQ-based
quantiﬁcation were searched against a mouse International
Protein Index (IPI) database (mouse, version 3.27, ∼56 000
Organelle Membrane Proteomics research articles
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2.0 software (Applied Biosystems). The major parameters in the
software were explained by Pierce et al.
24 Protein identiﬁcation
was based on a conﬁdence level >95% and at least two different
peptides assigned to the protein. A search performed against
a concatenated database containing both forward and reversed
sequences allowed estimation of the false discovery level (below
1%). The number of transmembrane helices in each protein
was predicted using the TMHMM online program (http://
www.cbs.dtu.dk/services/TMHMM/).
For relative protein quantiﬁcation, each protein ratio re-
ported by Protein Pilot was associated with a p-value (evaluat-
ing the statistical difference between the observed ratio and
unity) and EF (error factor) for each protein ID.
25 The EF term
indicates that the actual ratio lies between (reported ratio)/
(EF) and (reported ratio) × (EF) at a 95% conﬁdence. The
following criteria were required to consider a change in protein
level signiﬁcant: the protein ID had a p-value < 0.05 and a
meaningful EF (<2), at least two unique peptides were identi-
ﬁed, and the fold difference was greater than 1.25 (i.e., the ratio
was >1.25 or <0.80) as explained in Results and Discussion.
Immunoblots. Proteins from the LBC-phagosome mem-
brane extracts were separated by SDS-PAGE (4-12% acrylamide
for most experiments, 12% acrylamide gel for LC3 detection)
and analyzed by Western blot using appropriate antibodies.
For each sample, 3 µg of protein was loaded. Mouse tubulin
was probed as a loading control.
Live Cell Imaging of Autophagy Marker LC3. RAW264.7 cells
stably expressing GFP-fused LC3 (kindly provided by Patrick
Fitzgerald, St. Jude’s Children’s Research Hospital, Memphis,
TN) were used to investigate LC3 trafﬁcking after internalization
of lipoglycan-coated latex beads. The cells were cultured in
DMEM (GIBCO, containing high-glucose, glutamine, and so-
dium pyruvate) supplemented with nonessential amino acids
(GIBCO), 10% fetal bovine serum, and 100 units/mL penicillin/
streptomycin. Cells were seeded onto 8-well, Nunc Lab-Tek
Chambered Coverglass microscopy slides (Fisher) 20 h before
images were acquired. After incubation with lipoglycan-coated
beads for 2 h, cells were gently washed with PBS twice to
remove free beads. The cells were then treated with LysoTracker
Red DND-99 (Molecular Probes) (100 nM) for 15 min. The cells
were rinsed and incubated in fresh warm media and imaged
using a Zeiss 200 M epiﬂuorescence deconvolution microscope.
All images were processed using the nearest neighbor decon-
volution algorithm in the instrument software Slidebook 4.2
(Intelligent Imaging Innovations). In a separate experiment, the
cells were incubated with the autophagy inducer chloroquine
(50 µM) and a given bacterial lipoglycan at various concentra-
tions. After 2 h, the cells were washed with PBS and placed in
warm media for ﬂuorescence imaging.
Results and Discussion
Quantitative Membrane Proteomics of Phagosomes by
Combining Tube-Gel Digestion and iTRAQ Labeling. Previ-
ously, we reported a workﬂow for LBC phagosome isolation,
membrane fractionation, and proﬁling of the phagosome
membrane proteome by mass spectrometry.
20 Here, we modi-
ﬁed our platform to include the use of the iTRAQ method for
multiplexed protein quantitation.
22,26 Figure 2 illustrates the
workﬂow of the entire experiment. First, we coated latex beads
with a lipoglycan from M. tuberculosis (ManLAM), M. smeg-
matis (PILAM), or E. coli (LPS). The efﬁciency of lipid coating
was veriﬁed by speciﬁc staining of ManLAM-coated beads with
FITC-conjugated Concanavalin-A, a lectin that binds terminal
mannose residues
27 (Supporting Information SI Figure 1).
Figure 2. Experimental design for quantitative analysis of the phagosomal membrane proteome under different lipoglycan treatments.
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reported by Desjardins and colleagues
23 and modiﬁed in our
previous work.
20 To enrich membrane-bound components, we
fractionated the phagosome based on our previous protocol
with one modiﬁcation: we performed an additional wash of
the membrane pellet using a low-salt buffer to remove a greater
proportion of highly abundant luminal proteins. This adjust-
ment allowed the identiﬁcation of a greater number of mem-
brane-associated proteins (vide infra).
A consequence of enriching the samples for membrane-
associated proteins is the requirement of high detergent
concentrations (>4% SDS) for their solubilization, which poses
a problem for in-solution trypsin digestion due to the loss of
enzyme activity. Additionally, the in-gel digestion method,
though compatible with high detergent concentrations, is not
amenable to subsequent chemical labeling reactions as re-
quired by the iTRAQ method. We attempted to solve these
problems using reduced amounts of SDS (0.2%) in solution as
well as a more detergent-resistant protease, Lys-C, prior to
trypsin digestion, but neither of these modiﬁcations gave
satisfactory results.
We turned our attention to the recent method of Tube-Gel
digestion, developed by Lu and Zhu, which has proven effective
for proteomic analysis of membrane proteins.
21,28 An advantage
of this method is that detergent can be washed from the
protein-impregnated gel prior to trypsinization. Furthermore,
the resulting peptide products can be released from the gel into
aqueous solution prior to chemical labeling. We modiﬁed the
Tube-Gel digestion method in three ways to better suit the
analysis of phagosomal membrane extracts: (1) NH4HCO3 was
replaced with TEAB, a primary amine-free buffer compatible
with iTRAQ reagents; (2) the residual protein solution that was
excluded from the gel matrix was subjected to a second gel
solidiﬁcation process, so as to minimize sample loss; and (3)
we performed the cysteine reduction and alkylation steps prior
to gel formation.
Using phagosomal membrane extracts as substrates, we
compared the efﬁciency of this modiﬁed Tube-Gel digestion
protocol to in-solution methods and analyzed the peptide
products by LC-MS. The total number of proteins identiﬁed
using different digestion protocols in three separate experi-
ments are shown in Supporting Information Table 1. The
modiﬁed Tube-Gel protocol identiﬁed three times as many
proteins as the best in-solution procedure (using dual enzymes
and 0.2% SDS). A recent publication by Han et al. also
highlights the robustness of the Tube-Gel method for process-
ing membrane proteins prior to iTRAQ labeling.
29
The digested peptides derived from untreated, ManLAM-,
PILAM-, or LPS-treated samples were labeled with iTRAQ114,
iTRAQ115, iTRAQ116, or iTRAQ117, respectively. The pooled pep-
tide mixture was subjected to 2D LC-MS/MS analysis both for
protein identiﬁcation and relative quantitation. Biological
replicates were analyzed either on a QSTAR Pulsar I or Elite
mass spectrometer, and the combined data sets produced a
total of 823 nonredundant proteins (Supporting Information
Table 2A). Notably, 540 of these proteins were not found in
our earlier phagosome membrane proteomics study.
20 A sum-
mary of overlapping and unique protein IDs from both data
sets is present in Supporting Information Table 3. We attribute
the superior performance of the new method to (1) the
additional low-salt wash, which depleted more soluble proteins
and enriched membrane proteins accordingly (Supporting
Information Figure 2B), and (2) the reduced sampling handling
required of the Tube-Gel method, which minimized contami-
nation with keratins.
Changes of Phagosomal Membrane Proteins in Response
to Lipoglycans. The iTRAQ isotopic labels were used to
calculate relative protein levels from lipoglycan-treated or
untreated samples. Supporting Information Table 2B provides
a list of 658 quantitative ratios (lipoglycan treated:untreated)
measured in two experimental replicates. The criteria for
selecting ratios that indicate signiﬁcant changes in protein
abundances are described in Experimental Procedures. Apply-
ing these ﬁlters allowed us to identify four protein subsets that
were regulated by (i) ManLAM alone, (ii) ManLAM and PILAM
but not LPS, (iii) ManLAM and LPS but not PILAM, or (iv) all
three lipoglycans. Because ManLAM has been implicated in M.
tuberculosis virulence, we focused our studies on the phago-
somal proteins that were speciﬁcally regulated by this lipoglycan.
Apart from the p-value ﬁlter, we applied a threshold of 1.25-
fold difference because: (1) the average technical and biological
variations for iTRAQ-based quantitation have been reported
to be (11% and (25%, respectively;
30 (2) precedents have
established that in some cases changes in protein level as low
as 1.2-fold can be biologically relevant;
31,32 (3) after applying
these criteria, we found 42 proteins speciﬁcally regulated by
ManLAM (Table 1), with the remaining unchanged proteins
covering 94% of all the proteins quantiﬁed in this study. This
value is higher than the percent of unchanged proteins found
in an analysis of biological replicates using iTRAQ.
30 Therefore,
our criteria deﬁned a suitable variation tolerance for identifying
potentially regulated proteins.
Of the 42 proteins found to be regulated by ManLAM, 24
were down-regulated compared to samples from untreated
macrophages. Lysosome-associated membrane protein 1
(LAMP1), the late endosome membrane marker CD63, and the
late endosome-speciﬁc small GTPase Rab7 were all in this
group, a ﬁnding that agrees with previous microscopy studies
showing diminished recruitment of these proteins to phago-
somes containing ManLAM-coated beads
13 or live M. tuber-
culosis.
3 In addition, lysosomal enzymes such as the cysteine
protease cathepsin D (CatD), and subunits of lysosomal vacu-
olar ATPase (v-ATPase) were down-regulated by 30-40% (Table
1). Loss of v-ATPase, a proton transporter, could explain the
reduced LysoTracker staining of phagosomes containing Man-
LAM-coated beads reported earlier.
15 Interestingly, we noticed
that the phagosomes containing ManLAM-coated beads par-
tially share the features of those harboring live M. tuberculosis.
Russell group has reported earlier that mycobacterium pha-
gosomes exclude v-ATPase to restrict vacuole acidiﬁcation
33
as well as reduce acquisition of the mature form of CatD.
34 In
Western blot analysis, we also observed reduced production
of the mature CatD in the ManLAM-containg phagosome
(Figure 3A), though to a less extent than that observed in the
live mycobacterium phagosome.
34 In summary, our proteomic
data are consistent with classical cell-based or biochemical
assays and suggest that ManLAM contributes to phagosome
maturation arrest.
Among the down-regulated species, we were particularly
interested in a protein of unknown function containing a zinc
ﬁnger FYVE domain (IPI00554920.5). This domain is known to
bind phosphatidylinositol 3-phosphate (PI3P),
35 a regulatory
phospholipid that mediates membrane trafﬁcking, endosomal
protein sorting, and multisubunit enzyme assembly via multiple
effectors.
36-39 Importantly, PI3P plays an essential role in
phagosomal acquisition of lysosomal constituents, and it is
Organelle Membrane Proteomics research articles
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Early endosome antigen 1 (EEA1), a protein that is known to
be required for phagolysosome biogenesis and that also
contains a FYVE domain, was also down-regulated by ManLAM.
By analogy, the uncharacterized protein may be a new PI3P-
binding effector involved in phagosome maturation and is
possibly modulated by the M. tuberculosis lipoglycan.
Eighteen proteins increased in abundance when cells were
treated with ManLAM-coated beads (Table 1). The small
GTPase Rab14 is critical for stimulating vesicle fusion specif-
ically between phagosomes and early endosomes rather than
late endosomes.
40 Overexpression of this regulatory protein is
known to prevent phagosomes containing dead mycobacteria
from maturing into bactericidal phagolysosomes.
40 ManLAM-
induced upregulation of Rab14 in phagosomes may promote
phagosome-early endosome fusion thereby stalling the matu-
ration process. Another protein in this group, vacuolar protein
sorting-associated protein 41 (Vam2p homologue), is also
known to concentrate in early endosomes.
41 The protein
interacts with multiple SNARE family members, which are
important vesicle fusion regulators.
41 The observation that
ManLAM up-regulates at least two known early endosomal
proteins suggests that its host phagosome resembles early
endosomes, a proposal that been previously put forth for M.
tuberculosis-containing phagosomes.
33,34,40,42,43
Table 1. Quantitative Changes of Phagosomal Proteins Regulated by ManLAM Treatment
a
biological process protein name ManLAM PILAM LPS
b
Down-Regulated Proteins
Membrane receptor/Signaling Mannose-6-phosphate receptor 0.75 1.04 1.30
CD63 0.67 1.06 1.27*
Scavenger receptor class B member 2 0.66 1.05 1.23*
Membrane structure and lipid rafts Lysosomal membrane glycoprotein 1 0.60 0.94 1.08*
Lysosomal membrane glycoprotein 2 0.76 1.02 1.02
Transmembrane protein 55A 0.79 0.80 0.89
Vesicular and protein trafﬁcking Early endosome antigen 1 0.55 0.96 1.04
Vesicle transport through interaction with
t-SNAREs homologue 1B
0.75 1.03 1.28
Rab-7A 0.71 1.08 1.14
Rab-7B 0.65 0.86 1.12*
Molecular transport Immune regulator 1, ATPase, H+ transporting 0.72 0.99 1.31*
ATPase, H+ transporting, lysosomal V0 subunit a 0.75 0.95 1.04*
Vacuolar ATP synthase subunit B 0.74 1.04 1.42
Vacuolar ATP synthase subunit E1 0.65 0.92 1.35
Vacuolar ATP synthase subunit S1 0.69 0.89 0.99
Vacuolar ATP synthase subunit C 0.79 1.09 1.40
Vacuolar ATP synthase subunit F 0.79 1.25 1.34
Vacuolar ATP synthase subunit d 0.71 0.98 1.15*
Vacuolar ATP synthase catalytic subunit A 0.79 0.96 1.28
Isoform 1 of Reticulon-4 0.78 0.88 0.94
Hydrolases Cathepsin Z 0.74 0.97 0.98
Lysosomal acid phosphatase 0.75 1.15 1.23
Metabolism Collectin subfamily member 12 0.79 0.92 0.88
Uncharacterized Zinc ﬁnger, FYVE domain containing 26 0.60 0.93 1.27
UP-Regualted Proteins
Membrane receptor/Signaling Transferrin receptor protein 1 1.34 0.96 1.05
Vesicular and protein trafﬁcking Vacuolar protein sorting-associated protein 41
homologue
1.50 0.96 1.04*
Rab-5A 1.33 1.10 0.91
Rab-5C 1.29 0.96 0.98
Rab-14 1.67 1.17 1.13*
Signaling Isoform 1 of Sequestosome-1 1.39 1.06 1.12
Isoform 2 of Sequestosome-1 1.82 1.10 1.19
Iron homeostasis Ferritin H subunit 1.50 1.28 1.06*
Protein folding Calnexin 1.53 1.01 1.40
Protein folding/antigen presentation Heat-shock protein 90B1 1.48 0.77 1.31
Hydrolases Tripeptidyl-peptidase 1 1.32 1.21 1.08
Metabolism N-acetylglucosamine-6-sulfatase 1.26 1.09 1.20
D-3-phosphoglycerate dehydrogenase 1.58 1.10 1.20*
Alpha-N-acetylglucosaminidase 1.37 1.08 1.07
Cell mobility and cytoskeleton Vimentin 1.82 1.12 1.26
Titin 1.28 0.99 1.20
Uncharacterized 24 kDa protein 1.30 0.99 1.02
Ddost 1.31 0.98 1.18
a The protein ratios represent the relative abundance of a speciﬁc protein in the phagosome bearing latex beads coated with ManLAM, PILAM, or LPS
vs uncoated beads. Macrophage cells were treated by latex beads coated with three different bacterial lipoglycans or uncoated beads, and proteins were
extracted from phagosomal membranes for quantitative comparison using iTRAQ isotopic labels. The protein ratios indicate relative changes of protein
levels in the phagosomes under a speciﬁc lipoglycan treatment in comparison with no treatment. Forty-two proteins were found to be signiﬁcantly
changed only by ManLAM treatment, which were summarized in this table.
b The ratio with an asterisk is the mean of two replicate measurements.
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performed immunoblotting to validate quantitative changes of
certain phagosomal proteins in response to ManLAM treat-
ment. LAMP1, CatD, and EEA1 were down-regulated in the
presence of ManLAM-coated beads compared to samples
treated PILAM-coated, LPS-coated or uncoated beads (Figure
3A). The observed down-regulation of EEA1 concurs with
Deretic and co-workers’ report that EEA1 is depleted from
phagosomes containing live M. tuberculosis.
44 By contrast,
transferrin receptor (TfR), an early endosome marker, was
found to be up-regulated in phagosomes containing ManLAM-
coated beads. This coincides with a previous report by Clemens
and Horwitz, showing that only the phagosomes harboring live
mycobacterium acquire transferrin added exogenously.
43 These
trends revealed by immunoblotting matched those observed
by quantitative mass spectrometry (Figure 3B).
The reduced levels of EEA1 in phagosomes containing
ManLAM-coated bead may have broad consequences for
vesicle fusion and membrane trafﬁcking. EEA1 is recruited to
organelles via its association with PI3P on organelle mem-
branes
45 and also interacts with syntaxin 6, a SNARE protein
that participates in the vesicular trafﬁc between the TGN and
the endocytic system including phagosomes.
46,47 Inhibition of
EEA1’s function causes reduced accumulation of syntaxin 6 in
phagosomes.
12 Likewise, we considered the possibility that
syntaxin 6 is depleted from phagosomes bearing ManLAM-
coated beads. Indeed, Western blot analysis showed that
syntaxin 6 was down-regulated in the presence of ManLAM-
coated beads (Figure 3C) while four other syntaxins (Stx3, 7, 8,
12) and two syntaxin-binding proteins (Stxbp2, 5) identiﬁed
by our proteomic analysis did not exhibit reduced levels upon
ManLAM treatment (Supporting Information Table 2B). Loss
of syntaxin 6 from phagosomal membranes may cause a global
reduction in the delivery of lysosomal components, including
v-ATPase and CatD, from the TGN to phagosomes.
Taken together, the proteomic and biochemical data are
consistent with the proposal that ManLAM undermines traf-
ﬁcking from the TGN to the phagosome, which is reported to
depend on the production of PI3P by the kinase Vps34.
48
Interestingly, we also observed LAMP1 down-regulated by
ManLAM treatment, yet this protein is thought to be delivered
to phagosomes in a PI3P-independent manner.
12,35 Therefore,
ManLAM may affect multiple trafﬁcking pathways that con-
tribute to maturation of the phagosome and its proteome.
ManLAM Diminishes Translocation of the Autophago-
some Marker LC3 to Phagosomal Membranes and Inhibits
Autophagosome Accumulation. A connection was recently
revealed between the pathways of phagosome maturation and
autophagy activation.
20 Autophagy serves as a means for the
removal of intracellular bacteria and viruses, apart from its
primary function of maintaining cytoplasmic homeostasis.
49-52
M. tuberculosis survival in infected macrophages is suppressed
by artiﬁcial induction of the autophagy response.
53 We previ-
ously observed that the autophagosomal marker LC3 is en-
riched on LBC phagosomal membranes upon autophagy ac-
tivation.
20 LC3 is not only a widely used marker but also an
essential component of the autophagy machinery.
54 Upon the
induction of autophagy, the 18-kDa cytosolic precursor LC3-I
is cleaved at its C-terminus and conjugated to phosphatidyle-
thanolamine, generating a 16-kDa form termed LC3-II.
55 Lipid-
modiﬁed LC3-II integrates into the membranes of autophago-
somes and undergoes either recycling or degradation when
autophagosomes fuse with lysosomes.
56
Given the importance of the autophagy pathway in the
macrophage response to M. tuberculosis and the role of LC3
in this process, we sought to determine whether ManLAM
affects the cellular distribution of LC3. Our proteomic data
suggested that LC3 levels were reduced by about 30% in
phagosomes containing ManLAM-coated beads (Figure 4A), an
observation that was conﬁrmed by Western blot analysis of
phagosomal membrane extracts prepared in the same manner
(Figure 4B). By contrast, LC3 was up-regulated in phagosomes
containing LPS-coated beads and essentially unchanged in
phagosomes containing PILAM-coated beads (Figure 4).
Figure 3. Effect of ManLAM on selected proteins involved in
phagosome maturation. (A) Immunoblot of phagosomal mem-
brane extracts from cells treated with different lipoglycans using
antibodies speciﬁc for endosomal markers and a lysosomal
protease. (B) Relative ratios of speciﬁc proteins measured in our
proteomic study. Each ratio represents the changes of a particular
protein in the presence of ManLAM-, PILAM-, or LPS-coated
beads relative to the uncoated beads. Ratios for LAMP1 and CatD
are shown as the mean values from two experiments. Tubulin
was used as loading control. (C) Immunoblot of syntaxin 6 in
phagosome membrane extracts under different lipoglycan treat-
ments. Note: this protein was not identiﬁed in the proteomic
analysis.
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lular localization of LC3, we monitored a GFP-LC3 fusion
protein in RAW264.7 murine macrophages upon treatment with
various lipid-coated and uncoated beads (Figure 5A). The
average number of microbeads bearing bright ﬂuorescence of
GFP per cell provided a metric of the relative amount of LC3
in the phagosomes (Figure 5B). Basal levels of GFP-LC3 were
observed in phagosomes containing uncoated beads, reﬂecting
the endogenous low autophagy activity in resting macrophages.
Additionally, these phagosomes stained with LysoTracker,
indicating successful fusion with lysosomes to become acidic
vacuoles. Phagosomes bearing PILAM-coated beads showed
similar levels of GFP-LC3 ﬂuorescence and LysoTracker staining
as in the presence of uncoated beads. In contrast, phagosomes
containing ManLAM-coated beads exhibited weaker GFP-LC3
ﬂuorescence than observed with uncoated beads, as well as
weaker LysoTracker staining. LPS-coated beads affected LC3
translocation to phagosomes in an opposite manner compared
to ManLAM-coated beads. In response to LPS-coated beads,
GFP-LC3 levels were increased in phagosomes, consistent with
previous observations that LPS activates the autophagy path-
way.
57
Next, we investigated the effects of the bacterial lipids on
LC3 distribution in the presence of chloroquine, an anti-
inﬂammatory drug that causes accumulation of autophago-
somes by preventing their fusion with lysosomes.
58 The drug
has been previously employed to facilitate measurements of
autophagic ﬂux in vivo.
58 RAW264.7 cells stably expressing GFP-
LC3 were treated by chloroquine in the absence or presence
of a given lipoglycan suspended in medium. Trypan blue
staining was performed to conﬁrm that the chemical and lipid
treatments did not affect cell viability (Supporting Information
Figure 3). Cells treated with chloroquine alone showed punctate
ﬂuorescence derived from GFP-LC3-II (Figure 6A), an indicator
of elevated autophagy activity.
55,57,59 Such punctate ﬂuores-
cence was barely observed in untreated cells due to lysosomal
degradation of autophagosomal LC3 in the absence of chlo-
roquine.
58 Cells treated with PILAM and chloroquine demon-
strated a distribution of GFP-LC3-II that was similar to that
observed with chloroquine treatment alone. However, GFP-
LC3II ﬂuorescence was signiﬁcantly more diffuse in cells that
were treated with ManLAM (Figure 6A). Quantitation of the
average number of GFP-LC3-II puncta (>1 µm) per cell in the
presence of the various bacterial lipids is shown in Figure 6B.
Similar data were obtained from cells treated with three
different doses of ManLAM, suggesting that the minimal
effective concentration could be even lower than the 2 µg/
mL used in our assay. Collectively, these data indicate that
ManLAM, but not PILAM or LPS, suppresses the accumulation
of autophagosomes induced by chloroquine. Thus, ManLAM
appears to interfere with the endogenous formation of autoph-
agic vacuoles, an early stage of autophagy activation.
Conclusions
Using a new platform for quantitative comparison of the
membrane proteomes of macrophage phagosomes, we identi-
ﬁed 823 proteins of which 42 were signiﬁcantly regulated by
ManLAM from M. tuberculosis but not PILAM derived from
nonpathogenic mycobacteria or E. coli LPS. Several ManLAM-
regulated proteins are known to be involved in vesicle trafﬁck-
ing pathways and phagosome maturation. Others have un-
Figure 4. The level of LC3 in phagosomal membranes is reduced
by ManLAM treatment. (A) Proteomic quantitation; (B) and
immunoblot of phagosomal membrane extracts using an anti-
LC3 antibody.
Figure 5. ManLAM reduces GFP-LC3 ﬂuorescence in LBC pha-
gosomes. (A) Translocation of GFP-LC3 to LBC phagosomes
under different lipoglycan treatment. RAW cells stably expressing
GFP-LC3 were allowed to internalize latex beads (3 µm) coated
with a lipoglycan for 2 h. Control cells were treated with lipid-
free beads. LysoTracker was added in the last 15 min to stain
acidic vacuoles. (B) Quantitation of GFP-LC3 colocalization with
phagosomes containing beads coated with different lipoglycans.
A total of 200-250 cells were sampled in each experiment to ﬁnd
out the average number of LBC phagosomes bearing GFP
ﬂuorescence in each cell. The data are mean values ( SD from
three separate experiments. *P < 0.05.
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their regulation by ManLAM suggests a role in membrane
trafﬁcking events important for endosomal fusion and interac-
tion with phagosomes.
We also found that ManLAM suppresses the accumulation
of LC3-II in both LBC phagosomes and autophagosomes,
whereas PILAM has no such effects. Given the established
importance of phagocytosis and autophagy in the macrophage
response to M. tuberculosis infection, it is possible that
ManLAM’s functions include interference in these critical
processes of innate immunity.
The direct molecular targets of ManLAM remain an open
question. Fratti et al. proposed Vps34, the kinase responsible
for PI3P production, as a possible target,
44 and indeed phago-
somes containing M. tuberculosis show retarded and reduced
acquisition of this critical trafﬁc-regulating lipid.
45 Delineating
the downstream effectors of ManLAM is likely to reveal new
players in phagosome maturation, autophagy activation, and
other pathways. As well, understanding the mechanisms by
which ManLAM undermines the macrophage response may
reveal new therapeutic avenues.
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